Hofland LJ - Search Results

1

Low circulating IGF-I bioactivity is associated with human longevity: findings in centenarians' offspring.

Vitale G, Brugts MP, Ogliari G, Castaldi D, Fatti LM, Varewijck AJ, Lamberts SW, Monti D, Bucci L, Cevenini E, Cavagnini F, Franceschi C, Hofland LJ, Mari D, Janssen J. Vitale G, et al. Among authors: hofland lj. Aging (Albany NY). 2012 Sep;4(9):580-9. doi: 10.18632/aging.100484. Aging (Albany NY). 2012. PMID: 22983440 Free PMC article.

2

The interrelationship between the anti-mitotic action of the somatostatin analog octreotide and that of cytostatic drugs and suramin.

Lamberts SW, van Koetsveld P, Hofland LJ. Lamberts SW, et al. Among authors: hofland lj. Int J Cancer. 1991 Jul 30;48(6):938-41. doi: 10.1002/ijc.2910480623. Int J Cancer. 1991. PMID: 1860738

3

The in vitro and in vivo effects of human growth hormone administration on tumor growth of rats bearing a transplantable rat pituitary tumor (7315b).

Binnerts A, Uitterlinden P, Hofland LJ, van Koetsveld P, Lamberts SW. Binnerts A, et al. Among authors: hofland lj. Eur J Cancer. 1990 Mar;26(3):269-76. doi: 10.1016/0277-5379(90)90221-e. Eur J Cancer. 1990. PMID: 2141483 Free article.

4

The interrelationship between the effects of insulin-like growth factor I and somatostatin on growth hormone secretion by normal rat pituitary cells: the role of glucocorticoids.

Lamberts SW, den Holder F, Hofland LJ. Lamberts SW, et al. Among authors: hofland lj. Endocrinology. 1989 Feb;124(2):905-11. doi: 10.1210/endo-124-2-905. Endocrinology. 1989. PMID: 2492219

5

A close correlation between the inhibitory effects of insulin-like growth factor-I and SMS 201-995 on growth hormone release by acromegalic pituitary tumours in vitro and in vivo.

Lamberts SW, van Koetsveld P, Hofland L. Lamberts SW, et al. Clin Endocrinol (Oxf). 1989 Oct;31(4):401-10. doi: 10.1111/j.1365-2265.1989.tb01264.x. Clin Endocrinol (Oxf). 1989. PMID: 2627746

6

Octreotide, but not bromocriptine, increases circulating insulin-like growth factor binding protein 1 levels in acromegaly.

de Herder WW, Uitterlinden P, van der Lely AJ, Hofland LJ, Lamberts SW. de Herder WW, et al. Among authors: hofland lj. Eur J Endocrinol. 1995 Aug;133(2):195-9. doi: 10.1530/eje.0.1330195. Eur J Endocrinol. 1995. PMID: 7544670 Clinical Trial.

7

IGFBP-3 is a poor parameter for assessment of clinical activity in acromegaly.

de Herder WW, van der Lely AJ, Janssen JA, Uitterlinden P, Hofland LJ, Lamberts SW. de Herder WW, et al. Among authors: hofland lj. Clin Endocrinol (Oxf). 1995 Oct;43(4):501-5. doi: 10.1111/j.1365-2265.1995.tb02623.x. Clin Endocrinol (Oxf). 1995. PMID: 7586626

8

Somatostatin receptors and disease: role of receptor subtypes.

Hofland LJ, Lamberts SW. Hofland LJ, et al. Baillieres Clin Endocrinol Metab. 1996 Jan;10(1):163-76. doi: 10.1016/s0950-351x(96)80362-4. Baillieres Clin Endocrinol Metab. 1996. PMID: 8734455 Free article. Review.

9

[Acromegaly; diagnosis and treatment].

van der Lely AJ, de Herder WW, Hofland LJ, Lamberts SW. van der Lely AJ, et al. Among authors: hofland lj. Ned Tijdschr Geneeskd. 1996 Jul 13;140(28):1436-40. Ned Tijdschr Geneeskd. 1996. PMID: 8766766 Review. Dutch. No abstract available.

10

Somatostatin analogs and receptors. Diagnostic and therapeutic applications.

Hofland LJ, Lamberts SW. Hofland LJ, et al. Cancer Treat Res. 1997;89:365-82. doi: 10.1007/978-1-4615-6355-6_17. Cancer Treat Res. 1997. PMID: 9204201 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

357 results

Search Page

Filters